Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C<i>gag</i>Vaccine in Healthy HIV-1-Uninfected AdultsMargaret Wecker, Donald S. Burke, Nina D. Russell et al.|Clinical and Vaccine Immunology|2012Cited by 68